Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine.
about
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugsThe chemopotentiation of cisplatin by the novel bioreductive drug AQ4NSelective delivery of therapeutic agents for the diagnosis and treatment of cancer.Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia.Emerging DNA topisomerase inhibitors as anticancer drugs.Tumor-activated prodrugs--a new approach to cancer therapy.Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in miceTaking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Radiation enhances the therapeutic effect of Banoxantrone in hypoxic tumour cells with elevated levels of nitric oxide synthase.Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response.Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.Enhancement of the antitumor effect of cyclophosphamide with the hypoxia-selective cytotoxin NLCQ-1 against murine tumors and human xenografts.A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N.Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
P2860
Q26774750-15841342-AA47-49BF-973A-EBCF01CE12DFQ28346061-437376B7-706F-4BF1-B913-707BD1932A1DQ33230098-9359B986-4194-48A5-92C2-290999755169Q34090988-3445A063-EFA0-416D-ABB2-D508DD607D7BQ35779294-A8B32F51-EB76-49D1-B475-895FD4AE6A14Q35964429-AF19090F-5D46-4A90-831B-AD4E6E9CC9CCQ36200146-97CED083-2425-408F-90A6-78BD1E7D3047Q36453630-C75279FA-44E7-4E33-9B9B-79B584A65CC7Q37426436-15808348-F436-46FC-AAC5-D4863558E182Q38722296-E553B31C-7DE7-481B-81A3-505D9AF8EBEEQ39292683-D79D084E-64E3-4180-A536-4472C2175662Q40330281-FD9DCF68-7132-4915-9448-2B08D8D03A00Q44204636-90055DF7-81A6-4015-9A02-B02A73EC1C96Q45265957-1185E6F0-1359-4FEE-B56D-57E7FD53BE2DQ51693639-09C23EF0-16A1-4613-B1F7-0CDE89EFFCE7
P2860
Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@ast
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@en
type
label
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@ast
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@en
prefLabel
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@ast
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@en
P2093
P2860
P356
P1476
Enhancement of the anti-tumour ...... e drugs AQ4N and tirapazamine.
@en
P2093
Gallagher R
Galligan ES
McIntyre IA
McKeown SR
Patterson LH
P2860
P2888
P304
P356
10.1054/BJOC.1999.1132
P407
P577
2000-04-01T00:00:00Z
P5875
P6179
1052719703